Literature DB >> 28903024

Neospora caninum in non-pregnant and pregnant mouse models: cross-talk between infection and immunity.

Adriana Aguado-Martínez1, Afonso P Basto2, Alexandre Leitão3, Andrew Hemphill4.   

Abstract

Neospora caninum is a cyst-forming coccidian which causes abortion in cattle, with a high economic impact globally. Vaccination is considered to be the most cost-effective strategy to control and prevent bovine neosporosis. However, there is no commercial vaccine available to date. To investigate this disease under laboratory conditions, mouse models were developed, and they have been efficiently used as an initial proof-of-concept platform to investigate different immunogenic formulations. We here provide a detailed review on the current knowledge on immunity against neosporosis in non-pregnant as well as pregnant mice, and present a general overview of the most relevant parameters that may be responsible for protective immunity, which in turn could be relevant for vaccine development. Despite the considerable differences in immunity between cattle and mice, it is essential to understand how mice respond immunologically to Neospora caninum infection and how this response influences congenital infection and offspring survival. In this context, pregnant mouse models play a key role, and allow correlation of the outcome of congenital neosporosis with specific immune mechanisms which could also be relevant in cattle.
Copyright © 2017 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immune response; Mouse models; Neospora caninum; Pregnancy-associated immunomodulation; Protection

Mesh:

Year:  2017        PMID: 28903024     DOI: 10.1016/j.ijpara.2017.09.001

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  13 in total

1.  Vaccine-Linked Chemotherapy Approach: Additive Effects of Combining the Listeria monocytogenes-Based Vaccine Lm3Dx_NcSAG1 With the Bumped Kinase Inhibitor BKI-1748 Against Neospora caninum Infection in Mice.

Authors:  Dennis Imhof; William Robert Pownall; Carling Schlange; Camille Monney; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C Van Voorhis; Anna Oevermann; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2022-06-27

2.  Towards the First Multiepitope Vaccine Candidate against Neospora caninum in Mouse Model: Immunoinformatic Standpoint.

Authors:  Morteza Shams; Bahman Maleki; Bahareh Kordi; Hamidreza Majidiani; Naser Nazari; Hamid Irannejad; Ali Asghari
Journal:  Biomed Res Int       Date:  2022-06-09       Impact factor: 3.246

3.  Protective Effect against Neosporosis Induced by Intranasal Immunization with Neospora caninum Membrane Antigens Plus Carbomer-Based Adjuvant.

Authors:  Alexandra Correia; Pedro Alves; Ricardo Fróis-Martins; Luzia Teixeira; Manuel Vilanova
Journal:  Vaccines (Basel)       Date:  2022-06-10

4.  Immediate Interferon Gamma Induction Determines Murine Host Compatibility Differences between Toxoplasma gondii and Neospora caninum.

Authors:  Rachel S Coombs; Matthew L Blank; Elizabeth D English; Yaw Adomako-Ankomah; Ifeanyi-Chukwu Samuel Urama; Andrew T Martin; Felix Yarovinsky; Jon P Boyle
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

5.  Determination of B and T Cell Epitopes in Neospora caninum Immune Mapped Protein-1 (IMP-1): Implications in Vaccine Design against Neosporosis.

Authors:  Naser Nazari; Bahareh Kordi; Bahman Maleki; Morteza Shams; Esfandiar Azizi; Hamidreza Majidiani; Razi Naserifar
Journal:  Biomed Res Int       Date:  2022-04-07       Impact factor: 3.411

6.  Interplay Between Reactive Oxygen Species and the Inflammasome Are Crucial for Restriction of Neospora caninum Replication.

Authors:  Caroline M Mota; Djalma de S Lima-Junior; Flávia Batista Ferreira França; Jhoan David Aguillón Torres; Patrício da Silva Cardoso Barros; Fernanda Maria Santiago; Joāo Santana Silva; José Roberto Mineo; Dario S Zamboni; Tiago W P Mineo
Journal:  Front Cell Infect Microbiol       Date:  2020-05-25       Impact factor: 5.293

7.  Endochin-Like Quinolones Exhibit Promising Efficacy Against Neospora Caninum in vitro and in Experimentally Infected Pregnant Mice.

Authors:  Nicoleta Anghel; Vreni Balmer; Joachim Müller; Pablo Winzer; Adriana Aguado-Martinez; Mona Roozbehani; Sovitj Pou; Aaron Nilsen; Michael Riscoe; J Stone Doggett; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2018-11-19

Review 8.  From Signaling Pathways to Distinct Immune Responses: Key Factors for Establishing or Combating Neospora caninum Infection in Different Susceptible Hosts.

Authors:  Ragab M Fereig; Yoshifumi Nishikawa
Journal:  Pathogens       Date:  2020-05-16

9.  A Listeria monocytogenes-Based Vaccine Formulation Reduces Vertical Transmission and Leads to Enhanced Pup Survival in a Pregnant Neosporosis Mouse Model.

Authors:  Dennis Imhof; William Robert Pownall; Camille Monney; Anna Oevermann; Andrew Hemphill
Journal:  Vaccines (Basel)       Date:  2021-11-26

10.  The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy.

Authors:  Pablo Winzer; Dennis Imhof; Nicoleta Anghel; Dominic Ritler; Joachim Müller; Ghalia Boubaker; Adriana Aguado-Martinez; Luis-Miguel Ortega-Mora; Kayode K Ojo; Wesley C VanVoorhis; Andrew Hemphill
Journal:  Front Vet Sci       Date:  2020-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.